1132 related articles for article (PubMed ID: 34352133)
1. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later.
Ekpanyapong S; Bunchorntavakul C; Reddy KR
J Viral Hepat; 2022 Jan; 29(1):4-20. PubMed ID: 34352133
[TBL] [Abstract][Full Text] [Related]
2. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
3. Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection.
Ekpanyapong S; Reddy KR
Gastroenterol Clin North Am; 2023 Mar; 52(1):13-36. PubMed ID: 36813421
[TBL] [Abstract][Full Text] [Related]
4. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
Thuluvath PJ; Robarts P; Chauhan M
J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection and liver involvement.
Luo M; Ballester MP; Soffientini U; Jalan R; Mehta G
Hepatol Int; 2022 Aug; 16(4):755-774. PubMed ID: 35767172
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune liver diseases and SARS-CoV-2.
Sgamato C; Rocco A; Compare D; Minieri S; Marchitto SA; Maurea S; Nardone G
World J Gastroenterol; 2023 Mar; 29(12):1838-1851. PubMed ID: 37032727
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease 2019 and the liver.
Esteban JP; Sobotka L; Rockey DC
Curr Opin Gastroenterol; 2022 May; 38(3):191-199. PubMed ID: 35275902
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
[TBL] [Abstract][Full Text] [Related]
9. Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury.
Lleo A; Cazzagon N; Rigamonti C; Cabibbo G; Lai Q; Muratori L; Carbone M;
Dig Liver Dis; 2022 Jun; 54(6):722-726. PubMed ID: 35410851
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection in patients with a normal or abnormal liver.
Cabibbo G; Rizzo GEM; Stornello C; Craxì A
J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
[TBL] [Abstract][Full Text] [Related]
11. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation.
Alqahtani SA; Barry M; Memish Z; Hashim A; Alfares MA; Alghamdi SA; Al-Hamoudi WK; Al-Judaibi B; Alhazzani W; Al-Tawfiq JA; Abaalkhail F
Saudi J Gastroenterol; 2021; 27(4):201-207. PubMed ID: 34100388
[TBL] [Abstract][Full Text] [Related]
12. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
Hoffman TW; Meek B; Rijkers GT; van Kessel DA
Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination.
Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L
World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617
[TBL] [Abstract][Full Text] [Related]
14. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and liver injury: An ongoing challenge.
Papagiouvanni I; Kotoulas SC; Pataka A; Spyratos DG; Porpodis K; Boutou AK; Papagiouvannis G; Grigoriou I; Vettas C; Goulis I
World J Gastroenterol; 2023 Jan; 29(2):257-271. PubMed ID: 36687117
[TBL] [Abstract][Full Text] [Related]
16. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic.
Vitale G; Gitto S; Marra F; Morelli MC
Intern Emerg Med; 2022 Jan; 17(1):15-24. PubMed ID: 34245423
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury.
Akkiz H
Viruses; 2023 May; 15(6):. PubMed ID: 37376587
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease.
Luxenburger H; Thimme R
Gut; 2023 Sep; 72(9):1783-1794. PubMed ID: 37316169
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and liver disease: mechanistic and clinical perspectives.
Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
